Hong Kong and Phnom Penh, Cambodia, June 22, 2021/PRNewswire/ – The Cambodian Ministry of Health has approved the commercialization of the INDICAID® COVID-19 rapid antigen test as part of the country’s efforts to control the recent surge in COVID-19 cases .
The Cambodian government has deployed rapid antigen tests such as INDICAID® to carry out large-scale screening in the capital Phnom Penh and surrounding areas, using the short time and convenience of test results to help the government quickly identify COVID-19 patients and curb the spread of the disease. These tests also led to better containment measures, effectively dividing the capital into red, orange, and yellow areas based on the number of cases and the risk of transmission. INDICAID® can also be retailed in Phnom Penh.
Ricky Chiu, founder and CEO of PHASE Scientific, said: “We believe that the accuracy, ease of use and affordability of our test kits will make INDICAID® play an important role in the screening work carried out by the Cambodian government in the region. Role.” Official manufacturer of the INDICAID® test kit. “We welcome the decision of the Cambodian government and look forward to using our rapid test kits to support its neighboring countries.”
Chiu stated that many countries have adopted INDICAID® to combat COVID-19. In Hong Kong where PHASE Scientific is headquartered, INDICAID® has been recognized by the government as a designated product for hospital and nursing home visits. It is the best-selling brand among similar products and has sold more than 2 million kits. It is also widely adopted by hospitals, government and private companies, supermarkets, hotels and schools for regular local and international screening.
INDICAID® COVID-19 Rapid Antigen Test is a CE-labeled lateral flow immunoassay designed to qualitatively detect SARS-CoV-2 antigen in direct nasal swab samples. With reliable product quality and ease of use, INDICAID® can quickly provide results within 20 minutes, without the need for special equipment or facilities. The accuracy of this test kit has been clinically verified in the world’s largest dual-track clinical trial, in which INDICAID® was tested against PCR in more than 9,200 samples and showed high sensitivity and specificity.
INDICAID® is currently available in 33 countries and is in the process of obtaining an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Author: John Vandermosten, CFA TSX: PMN.TO | OTC: ARFXF | NASDAQ: BIIB One of the craziest roller coasters in the biotechnology field is the aducanumab legend that has occurred in the past few years. Aducanumab, with the trademark Aduhelm, is an amyloid-directed monoclonal antibody for the treatment of Alzheimer’s disease (AD). Aduhelm binds to the aggregate form of amyloid and has
Private company Cantex Pharmaceuticals Inc has signed a license agreement with vTv Therapeutics Inc (NASDAQ: VTVT) to develop and commercialize vTv’s azeliragon. According to the terms of the agreement, Cantex will be responsible for the development and commercialization of azeliragon, and the two companies will distribute downstream profits under a hierarchical arrangement. No other financial details were disclosed. “Therefore, there is an opportunity to develop azeliragon, a phase 2 oral drug management
The enduring family business embodies the four key success factors that promote family cohesion, business growth and long-term wealth preservation.
Author: Dr. David Bautz Nasdaq: MNOV Read the full MNOV research report Business update MN-166 Phase 2 positive results of the Australian dollar trial June 21, 2021, MediciNova, Inc. (NASDAQ: MNOV ) Announcing the positive results of Phase 2 The trial of MN-166 (Ibudilast) in Alcohol Use Disorders (AUD) was published in the Nature publication Translational Psychiatry (Grodin et al., 2021). Trial is a
The world has accepted influenza vaccines with an efficiency of no more than 50%, so better products can reshape the market and possibly expand the market.
(Bloomberg)-New Zealand health officials are scrambling to trace the contacts of an Australian traveler from Sydney who visited Wellington over the weekend and was also infected with Covid-19. In view of the fact that this move may cause the Tokyo Olympics organizers to abandon the plan to sell alcohol in the venues, Kyodo News reported that it has contributed to the spread of the virus, but has no ownership. As officials are concerned about the emergence of new variants, China plans to maintain travel restrictions for at least another year. The White House admits
Enter the 10 new stages of life, remember to set foot on emotional protection for your own plans. www.vhis.gov.hk Check it out!
After several coronavirus outbreaks around the school, Israel recommends vaccinating young people, even fully vaccinated people can get the virus because the authorities blame the more contagious Delta variant. The country reported 125 new cases in 24 hours on Tuesday, the highest single-day total since the end of April. After random testing, the latest outbreak was found in several schools, and after Israel lifted almost all coronavirus restrictions
The daughter of an unvaccinated county employee in Florida died after COVID-19 swept through the government office building where she worked. She said that she and her family resolutely refused to be vaccinated, even though their mother’s colleague who was vaccinated was not sick at all. No one in my family gets vaccinated,” Molly Hart told the Daily Beast. Hart’s mother, Mary Knight, 58, died of COVID-19-related complications last week, Manatee County Identity Verification
In the Phase 2/3 study led by the Washington University School of Medicine, the experimental anti-amyloid antibodies of Eli Lilly and Company (NYSE: LLY) and Roche Holdings (OTC: RHHBY) failed to improve Al Symptoms of Zheimer’s disease (AD). year. Now, researchers say they have evidence that Roche’s gantenerumab can help some patients. Among the trial participants in Dominant Alzheimer’s Disease (DIAD), Roche’s
No.1 micro-plan discount: 5 bottom-cost options [$0 to $75000], with the company’s medical insurance to offset the insurance to enjoy the annual protection of 30 million.
Jewish General Hospital (JGH) is a member institution of the Montreal Midwestern Health Service (CIUSSS) and is the first to join Auger Groupe Conseil Inc. (AGC) and Medtronic Canada ULC (a subsidiary of Medtronic (NYSE: MDT)) Use Microsoft HoloLens for real-time, extended reality (XR) clinical support for minimally invasive cardiac surgery.
Dr. Susannah Hills, a Pediatric Airway Surgeon and Assistant Professor of Otolaryngology at Columbia University Medical Center, joined Yahoo Finance to discuss the latest news about the coronavirus pandemic.
When researchers looked at the marijuana habits of a group of people between 18 and 30 years old, another discovery 25 years later went beyond the fog.
The images provided by Pixaby Biotechnology have been the source of some of the most important medical discoveries in the world in recent years. Many of the most breakthrough advancements, including COVID-19 vaccines, epidemic tracking technology, and virtual biobanks, have come from startups and small companies. There are thousands of such startups in the biotechnology field. Their pioneering spirit and rapid adaptability put these companies in a leading position in the biomedical industry. Here are some
Mongolia promised its people a “Summer without Covid-19″. Bahrain said it would “return to normal life.” The small island nation of Seychelles aims to start its economy. All three believe at least to some extent in the easily available vaccines made in China, which will enable them to launch ambitious vaccination programs when they are not available in most parts of the world. However, all three countries are now fighting the surge in infections rather than getting rid of the coronavirus. registered
UniQure NV (NASDAQ: QURE) announced the 52-week data of etranacogene dezaparvovec for the treatment of hemophilia B in its phase 3 HOPE-B gene therapy trial. Data show that 52 weeks after treatment of hemophilia B, the activity of factor IX (FIX) continued to increase. During the 26-week follow-up, the average FIX activity infused was 41.5% of the normal value, and the average FIX activity was 39% of the normal value. FIX is a protein naturally produced in the body, which helps blood form a clot to stop bleeding. During these 52 weeks, a single
“Good news: Our vaccine is effective against Delta variants,” Fauci added. “This variant represents a set of mutations that may lead to mutations that evade our vaccine in the future. This is why vaccinations are now more effective than ever before. Time is more important in order to stop the chain of infection-the chain of mutations that can lead to more dangerous mutations,” said Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC). The Delta variant caused a severe COVID-19 outbreak in India in April and May, overwhelming the country’s health services and causing hundreds of thousands of deaths.
The German biotechnology company BioNTech SE (BNTX) revealed that in its Phase II trial of the BNT111 cancer vaccine for advanced melanoma, the first patient has been administered the drug. BioNTech is a pioneer in immunotherapy for cancer, infectious diseases and other chronic diseases. The company has a broad portfolio of tumor treatment candidates, protein replacement therapies, small molecule immunomodulators, novel antibodies and cell therapies. The second phase of the trial is studying the efficacy of BNT111 admin
A new study published in JAMA found that 45 men who received the COVID-19 mRNA vaccine had no differences in sperm parameters. Two authorized mRNA vaccines developed by Pfizer and Moderna are the most commonly used COVID-19 vaccines in the United States. Researchers at the Miller School of Medicine at the University of Miami said that they started the study after hearing some people’s concerns. . It is believed that vaccines may affect fertility. They pointed out that this study has some limitations
Atai Life Sciences (NASDAQ: ATAI) made its debut on NASDAQ on Friday. The Berlin-based company will join the exclusive start-up group in the psychedelic industry and will be listed on NASDAQ this year, including MindMed (NASDAQ: MNMD) and Compass Pathways (NASDAQ) Code: CMPS). With the support of Peter Thiel, the founder of PayPal (NASDAQ: PYPL), the company has raised more than $362 million in funding since its establishment in 2018. Atai raised another $225 million in its initial public offering on Thursday.
Dr. Ron Friedman, a social psychologist and author of the book “Decoding the Great,” told Yahoo Finance Live that the changes brought about by the COVID-19 pandemic will trigger “a revolution in the way organizations operate.”
Post time: Jun-23-2021